XNAS: RNA
Atrium Therapeutics Inc Live Stock Price Today, Share Analysis and Chart
about
Atrium Therapeutics Inc is a biopharmaceutical firm focused on developing RNA-based therapeutics for cardiac conditions, including cardiomyopathies. Its platform technology is designed to enable targeted delivery of RNA therapeutics to heart tissue b...
Read More
9.19
0.24
(2.68%)
481.3K
XNAS Volume
XNAS 21 Sep, 2026 5:30 PM (EDT)
Low Financial Strength
Expensive Valuation
Technically Bearish
Weak Stock
These stocks have poor scores across the board. Investors should be very cautious with these stocks
View Similar
Embed DVM
Atrium Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..